Our Programs
Roots to Thrive
Ketamine (group)
Highlights
- 12 weekly virtual community of practice meetings
- Small group supported by two regulated professionals
- 3 ketamine-assisted therapy sessions with your small group
- Multiple integration and education sessions
- Physician referral required by a primary care physician (Family Doctor, Nurse Practitioner or treating Psychiatrist)
- Please note: out of province participants are subject to a higher price
Program Cost: $5850 + tax
Roots to Thrive
Psilocybin (group)
Highlights
- 8-10 weekly virtual community of practice meetings
- Small group supported by two regulated professionals
- 1 psilocybin-assisted therapy session with your small group
- Multiple education and integration sessions
- Physician referral required
- Please note: out of province participants are subject to a higher price
Program Cost: $2800 + tax
Roots to Thrive
Training: KAT Experiential Intensive
Highlights
This arm of Roots to Thrive (RTT) programming includes 45 hours of treatment and training in a supervised practice environment (In person weekend on Vancouver Island, BC).
The Curriculum is a blend of virtual and in person:
- 2 Virtual KAT prep sessions.
- In person: offering of 2 KAT experiences as a participant and 2 KAT experiences as a supporter.
- Virtual Integration session
- RTT Facilitated sessions: 2 prep sessions and 1 integration session surrounding KAT experiences
- Peer Facilitated sessions: One 1:1 prep session and one 1:1 integration session
REQUIREMENTS TO PARTICIPATE: Physician referral form (will receive upon registration), verification of psychedelic medicine theory completion, verification of experience as a mental health practitioner.
MINIMUM PARTICIPATION: Roots to Thrive is a non-profit organization and requires a certain number of participants to put the training on to ensure we are able to cover our costs.
READY TO REGISTER? go to the apply section and fill in your information. For program select “RTT Training: Experiential Intensive” and for Cohort select “Training Experiential Intensive: Cohort 1”. Once you register you will receive a follow up email with further directions.
Email krys@rootstothrive.com with any questions.
Program Cost: $4500 + tax
Program Eligibility
Unique eligibility requirements exist for each of our programs
Roots to Thrive
Ketamine (group)
Prerequisites
- PTSD
- Depression
- Substance use disorder
- Anxiety
- Disordered eating
- Disordered sleep
Exclusions
- Uncontrolled or untreated hypertension (above 150/90)
- Some hepatic disorders (reviewed case by case)
- Some kidney disorders (reviewed case by case)
- Some vascular disorders (reviewed case by case)
- Presence of active psychotic symptoms
- Dementia
- Delirium
- Inability to tolerate group work
- Extreme emotional instability
- Ketamine allergy
- Pregnancy
- Medications that reduce the effectiveness of Ketamine:
- Benzodiazepines
- Lamotrigine
- Buprenorphine
Roots to Thrive
Psilocybin (group)
Prerequisites
- Terminal diagnosis with limited life expectancy
- Ambulatory
- eGFR >20 ml/min
- AST < 3xULN and bilirubin <50 umol/L
- Emotional distress that has not successfully responded to other treatments: other treatments failed, patient could not tolerate other treatments, patient is unable to access other treatments, or patient refused other treatments for reasons acceptable to our treatment team.
- Patient demonstrates comprehension sufficient for understanding the consent form.
Exclusions
- Treatment in clinical trial where psilocybin would exclude patient from continuing to recieve treatment.
- Pregnancy or lactation
- Poorly controlled insulin-dependent diabetes
- Currently taking on a daily basis: investigational agents, or MAO inhibitors.
- Patients taking MAO-A inhibitors (especially the irreversible inhibitors) will require a minimum 2-week washout period. The possible concern over serotonin syndrome with these agents is not well documented in the literature, however the long interval before MAO is replenished may warrant a cautious approach based on the patient’s risk factors and warrants oversight from the MRP (Most Responsible Physician)
- Patients taking MAO-B inhibitors should be assessed on a case by case basis as there is a potential for a heightened response and warrants oversight from the MRP.
- Active uncontrolled epilepsy.
- Cancer has central nervous system involvement.
- Paraneoplastic syndrome or a tumor with ectopic hormone production which may place the patient at risk for hypercalcemia, Cushing’s syndrome, or SIADH secretion.
- Uncontrolled cardiovascular conditions: uncontrolled hypertension, uncontrolled angina, a clinically significant ECG abnormality (e.g. QT prolongation).
- Uncontrolled vascular disease (such as TIA in the last 3-6 months, stroke with loss in mental status, peripheral or pulmonary vascular disease with active claudication).
- Severity of depression or anxiety symptoms warranting immediate emergent treatment with antidepressant or daily anxiolytic medication (e.g., due to suicidal ideation) as these patients would require immediate referral to community psychiatry.
- Current or past history of meeting DSM-5 criteria for (the following diagnoses must have been confirmed by a qualified psychiatrist or psychologist):
- Schizophrenia;
- Psychotic Disorder (unless substance-induced or due to a medical condition);
- Borderline Personality Disorder;
- Bipolar I Disorder;
- Bipolar II Disorder;
- Other psychiatric conditions judged to be incompatible with establishment of rapport or safe exposure to psilocybin.
- Borderline Personality Disorder, Bipolar I Disorder and Bipolar II Disorder may be considered after a psychiatric consult.
- Bipolar I would require more in-depth investigation in relation to the history of manic episodes.
- Meet DSM-5 criteria for Dissociative Disorder
- Concurrent use of illicit drugs causing ongoing intoxication
- Unstable housing conditions (homelessness)
Conditions requiring special psychiatric consideration:
- First degree relatives meet DSM-5 criteria for Bipolar Disorder or Schizophrenia.
Roots to Thrive
Training: KAT Experiential Intensive
Prerequisites
A diagnosis of one or more of the following:
- PTSD
- Depression
- Substance use disorder
- Anxiety
- Disordered eating
- Disordered sleep
Exclusions
- Uncontrolled or untreated hypertension (above 150/90)
- Some hepatic disorders (reviewed case by case)
- Some kidney disorders (reviewed case by case)
- Some vascular disorders (reviewed case by case)
- Presence of active psychotic symptoms
- Dementia
- Delirium
- Inability to tolerate group work
- Extreme emotional instability
- Ketamine allergy
- Pregnancy
- Medications that reduce the effectiveness of Ketamine:
- Benzodiazepines
- Lamotrigine
- Buprenorphine
Intake Process
Step 2
Step 3
Step 4
FAQs
We work collaboratively with the participants’ primary mental health care provider to ensure collaborative safe care. This is a time limited program which compliments other forms of treatment. This is not a substitute for other forms of care and expect participants to maintain a relationship with their care team outside of Roots to Thrive including their referring provider.
- The program is not yet covered. Some of the physician fees are.
- WorkSafe has covered some participants.